Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

Affiliations

• ¹ Department of Hematology, University of California at San Francisco, San Francisco, CA, USA. Tom.Martin@ucsf.edu.
• ² The National and Kapodistrian University of Athens, Athens, Greece.
• ³ Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA.
• ⁴ Department of Haematology, University College Hospital, London, UK.
• ⁵ Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil.
• ⁶ Department of Haematology, Lille University Hospital, Lille, France.
• ⁷ Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
• ⁸ Department of Hematology, 1st Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic.
• ⁹ Perth Blood Institute, Murdoch University, Perth, Australia.
• ¹⁰ Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
• ¹¹ Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
• ¹² Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
• ¹³ Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
• ¹⁴ Service d'Hématologie et Thérapie Cellulaire, CHU and CIC Inserm, 1402, Poitiers Cedex, France.
• ¹⁵ Institut Josep Carreras and Institut Catala d'Oncologia, Hospital Germans Trias I Pujol, Badalona, Spain.
• ¹⁶ Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
• ¹⁷ Myeloma/Amyloidosis Center, Japanese Red Cross Medical Center, Tokyo, Japan.
• ¹⁸ Ividata Life Science, Levallois-Perret, France.
• ¹⁹ Sanofi, R&D, Chilly-Mazarin, France.
• ²⁰ Sanofi, R&D, Vitry-sur-Seine, France.
• ²¹ Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.